Concepedia

Publication | Open Access

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

DOIFull Paper Access

1.4K

Citations

14

References

2012

Year

Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro, Luc Dirix, Karl D. Lewis, John D. Hainsworth, James Solomon, Simon Yoo, Sarah T. Arron, Philip Friedlander,
New England Journal of Medicine

Abstract

Vismodegib is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma. (Funded by Genentech; Erivance BCC ClinicalTrials.gov number, NCT00833417.).

References

YearCitations

Page 1